In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine

Published:2016-12 Issue:6 Volume:26 Page:572-579
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Sadhu Satya S.,Wang Shenggang,Averineni Ranjith K.,Seefeldt Teresa,Yang Yang,Guan Xiangming

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference49 articles.

1. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention;Fajardo;Am J Physiol Gastrointest Liver Physiol,2015

2. Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in vitro and in vivo;Dai;Cancer Cell Int,2012

3. Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2;Xu;Eur J Pharmacol,2015

4. Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies;Harris;Subcell Biochem,2007

5. Dual cyclooxygenase and carbonic anhydrase inhibition by nonsteroidal anti-inflammatory drugs for the treatment of cancer;De Monte;Curr Med Chem,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silver(I) complexes with diorganochalcogen ligands of type (2-MeC6H4CH2)2E (E = S, Se). Synthesis, structure and antiproliferative activity;Inorganica Chimica Acta;2024-05

2. Investigating Therapeutic Efficacy of Dacarbazine and Temozolomide, Alone and in Combination with BRAF(V600E) siRNA in A375 Human Melanoma Cell Line;2024-04-03

3. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AS REPURPOSED ANTICANCER DRUGS IN SKIN CANCER;FARMACIA;2024

4. Schisandrin B Inhibits Cell Viability and Malignant Progression of Melanoma Cells via Wnt/β-catenin Signaling Pathway;Anti-Cancer Agents in Medicinal Chemistry;2023-09

5. The Association of Improved Overall Survival with NSAIDs in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors;Clinical Lung Cancer;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3